Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125006613 | 12500661 | 3 | F | 20160514 | 20160829 | 20160627 | 20160901 | EXP | US-PFIZER INC-2016311862 | PFIZER | 65.00 | YR | M | Y | 125.00000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125006613 | 12500661 | 1 | PS | ZYVOX | LINEZOLID | 1 | Oral | 600 MG, 2X/DAY | 21130 | 600 | MG | FILM-COATED TABLET | BID | ||||||
| 125006613 | 12500661 | 2 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 5MG TABLET 2 OR 3 A DAY | 0 | 5 | MG | TABLET | |||||||
| 125006613 | 12500661 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 125006613 | 12500661 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 125006613 | 12500661 | 5 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD | ||||||
| 125006613 | 12500661 | 6 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD | ||||||
| 125006613 | 12500661 | 7 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 100 MG, AS NEEDED | 0 | 100 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125006613 | 12500661 | 1 | Infection prophylaxis |
| 125006613 | 12500661 | 2 | Diabetes mellitus |
| 125006613 | 12500661 | 3 | Cardiac disorder |
| 125006613 | 12500661 | 4 | Urinary tract disorder |
| 125006613 | 12500661 | 5 | Vitamin supplementation |
| 125006613 | 12500661 | 6 | Asthenia |
| 125006613 | 12500661 | 7 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125006613 | 12500661 | OT |
| 125006613 | 12500661 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125006613 | 12500661 | Abdominal pain upper | |
| 125006613 | 12500661 | Cerebrovascular accident | |
| 125006613 | 12500661 | Chest pain | |
| 125006613 | 12500661 | Dehydration | |
| 125006613 | 12500661 | Dizziness | |
| 125006613 | 12500661 | Dyspnoea | |
| 125006613 | 12500661 | Fall | |
| 125006613 | 12500661 | Unresponsive to stimuli | |
| 125006613 | 12500661 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125006613 | 12500661 | 1 | 20160512 | 0 | ||
| 125006613 | 12500661 | 3 | 2014 | 0 |